{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:16:31Z","timestamp":1784798191670,"version":"3.55.0"},"reference-count":56,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015021","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T06:49:16Z","timestamp":1660027756000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review"],"prefix":"10.1002","volume":"2022","author":[{"given":"Nina","family":"Kreuzberger","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marike","family":"Andreas","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine; University Hospital Wuerzburg; Wuerzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Br\u00f6ckelmann","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD); Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"},{"name":"Max-Planck Institute for the Biology of Ageing; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Di Cristanziano","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Institute of Virology; University Hospital of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Golinski","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology; University of Goettingen Medical Center; Goettingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate Ilona","family":"Hausinger","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Mellinghoff","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD); Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"},{"name":"German Centre for Infection Research (DZIF); partner site Bonn-Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Helmholtz Centre for Infection Research; Brunswick Germany"},{"name":"Translational Unit BBD; German Center for Infection Research (DZIF); Brunswick Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Lischetzki","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Kappler","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Mikolajewska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine; Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin; Berlin Germany"},{"name":"Centre for Biological Threats and Special Pathogens (ZBS), Strategy and Incident Response (ZBS7), Clinical Management and Infection Control (ZBS7.1); \u00a0Robert Koch Institute; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Monsef","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Soo","family":"Park","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Piechotta","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schmaderer","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Stegemann","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine; Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vanshylla","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Institute of Virology; University Hospital of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine; University Hospital Wuerzburg; Wuerzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Weibel","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine; University Hospital Wuerzburg; Wuerzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caspar","family":"Stephani","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology; University of Goettingen Medical Center; Goettingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"10.1002\/14651858.CD015021-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1056\/NEJMoa2200797","article-title":"Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015021-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.24875\/BMHIM.20000217","article-title":"Development of SARS-CoV-2 vaccines","volume":"78","author":"Barajas-Nava","year":"2021","journal-title":"Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico"},{"key":"10.1002\/14651858.CD015021-BIB0003|cit3","unstructured":"Basta NE Moodie EMM on behalf of the VIPER (Vaccines Infectious disease Prevention and Epidemiology Research) Group COVID-19 Vaccine Development and Approvals Tracker Team COVID-19 vaccine tracker covid19.trackvaccines.org\/vaccines\/"},{"issue":"7","key":"10.1002\/14651858.CD015021-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/infdis\/jiab592","article-title":"Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults","volume":"225","author":"Brockmann","year":"2022","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015021-BIB0005|cit5","unstructured":"Centers for Disease Control and Prevention Joint statement from HHS Public Health and medical experts on COVID-19 booster shots www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/booster-shot.html"},{"key":"10.1002\/14651858.CD015021-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"key":"10.1002\/14651858.CD015021-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1002\/14651858.CD015021-BIB0008|cit8","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD015021-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(21)02844-0","article-title":"Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum","volume":"399","author":"Dejnirattisai","year":"2022","journal-title":"Lancet"},{"issue":"32","key":"10.1002\/14651858.CD015021-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015021-BIB0011|cit11","unstructured":"European Medicines Agency Human regulatory - COVID-19 vaccines www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/covid-19-vaccines"},{"key":"10.1002\/14651858.CD015021-BIB0012|cit12","unstructured":"European Medicines Agency EMA recommends Nuvaxovid for authorisation in the EU www.ema.europa.eu\/en\/news\/ema-recommends-nuvaxovid-authorisation-eu"},{"issue":"10328","key":"10.1002\/14651858.CD015021-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015021-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1002\/14651858.CD015021-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD015021-BIB0016|cit16","unstructured":"Hausinger R Bachmann Q Crone-Rawe T Hannane N Schmaderer C Kreuzberger N Efficacy, immunogenicity and harms of SARS-CoV-2 booster vaccination for kidney transplant recipients: a systematic review osf.io\/nsyq4"},{"issue":"23","key":"10.1002\/14651858.CD015021-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD015021-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S2213-2600(21)00357-X","article-title":"Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study","volume":"9","author":"Hillus","year":"2021","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD015021-BIB0019|cit19","unstructured":"International Initiative for Impact Evaluation Evidence gap maps www.3ieimpact.org\/evidence-hub\/evidence-gap-maps"},{"issue":"7","key":"10.1002\/14651858.CD015021-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nature Medicine"},{"issue":"7830","key":"10.1002\/14651858.CD015021-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"issue":"10308","key":"10.1002\/14651858.CD015021-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(21)02046-8","article-title":"Considerations in boosting COVID-19 vaccine immune responses","volume":"398","author":"Krause","year":"2021","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015021-BIB0023|cit23","unstructured":"Kreuzberger N Hirsch C Andreas M B\u00f6hm L Br\u00f6ckelmann PJ Di Cristanziano V Immunity after COVID-19 vaccination: protocol for a scoping review doi.org\/10.17605\/OSF.IO\/HTGB8 10.17605\/OSF.IO\/HTGB8"},{"key":"10.1002\/14651858.CD015021-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"e068632","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of COVID-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015021-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41591-021-01575-4","article-title":"Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2","volume":"27","author":"Levine-Tiefenbrun","year":"2021","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015021-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/jnci\/djab174","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients","volume":"114","author":"Ligumsky","year":"2022","journal-title":"Journal of the National Cancer Institute"},{"issue":"645","key":"10.1002\/14651858.CD015021-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"eabn8543","DOI":"10.1126\/scitranslmed.abn8543","article-title":"SARS-CoV-2 BA.1 variant is neutralized by vaccine booster\u2013elicited serum but evades most convalescent serum and therapeutic antibodies","volume":"14","author":"Lusvarghi","year":"2021","journal-title":"Science Translational Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015021-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"e00733","DOI":"10.1128\/Spectrum.00733-21","article-title":"Serological assays for assessing postvaccination SARS-CoV-2 antibody response","volume":"9","author":"Mahmoud","year":"2021","journal-title":"Microbiology Spectrum"},{"issue":"10","key":"10.1002\/14651858.CD015021-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015021-BIB0030|cit30","unstructured":"Microsoft Excel Microsoft Corporation 2018"},{"issue":"3","key":"10.1002\/14651858.CD015021-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/infdis\/jiaa659","article-title":"Longitudinal serological analysis and neutralizing antibody levels in Coronavirus disease 2019 convalescent patients","volume":"223","author":"Muecksch","year":"2020","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD015021-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/jcm11092565","article-title":"Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients","volume":"11","author":"Osmanodja","year":"2022","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD015021-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"117956","DOI":"10.1016\/j.lfs.2020.117956","article-title":"Vaccination strategies to combat novel corona virus SARS-CoV-2","volume":"256","author":"Pandey","year":"2020","journal-title":"Life Sciences"},{"issue":"30","key":"10.1002\/14651858.CD015021-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1016\/j.vaccine.2021.05.099","article-title":"Evaluation of post-introduction COVID-19 vaccine effectiveness: summary of interim guidance of the World Health Organization","volume":"39","author":"Patel","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015021-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"e00247","DOI":"10.1128\/Spectrum.00247-21","article-title":"Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays","volume":"9","author":"Perkmann","year":"2021","journal-title":"Microbiology Spectrum"},{"issue":"5","key":"10.1002\/14651858.CD015021-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41408-022-00684-8","article-title":"Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review","volume":"12","author":"Piechotta","year":"2022","journal-title":"Blood Cancer Journal"},{"key":"10.1002\/14651858.CD015021-BIB0037|cit37","unstructured":"Ontario Agency for Health Protection and Promotion COVID-19 real-world vaccine effectiveness \u2013 what we know so far www.publichealthontario.ca\/-\/media\/documents\/ncov\/covid-wwksf\/2021\/04\/wwksf-vaccine-effectiveness.pdf?sc_lang=en"},{"issue":"1","key":"10.1002\/14651858.CD015021-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/diagnostics12010205","article-title":"Assessing SARS-CoV-2 neutralizing antibodies after BNT162b2 vaccination and their correlation with SARS-CoV-2 IgG anti-S1, anti-RBD and anti-S2 serological titers","volume":"12","author":"Ramos","year":"2022","journal-title":"Diagnostics"},{"key":"10.1002\/14651858.CD015021-BIB0039|cit39","unstructured":"R: A language and environment for statistical computing R Core Team R Foundation for Statistical Computing 2020"},{"key":"10.1002\/14651858.CD015021-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s40121-021-00475-x","article-title":"In search of the SARS-CoV-2 protection correlate: head-to-head comparison of two quantitative S1 assays in pre-characterized oligo-\/asymptomatic patients","volume":"10","author":"Rubio-Acero","year":"2021","journal-title":"Infectious Diseases and Therapy"},{"key":"10.1002\/14651858.CD015021-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41591-021-01464-w","article-title":"Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens","volume":"27","author":"Schmidt","year":"2021","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD015021-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma neutralization of the SARS-CoV-2 Omicron variant","volume":"386","author":"Schmidt","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD015021-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"e157836","DOI":"10.1172\/jci.insight.157836","article-title":"Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients","volume":"7","author":"Schrezenmeier","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"10.1002\/14651858.CD015021-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3201\/eid2708.211145","article-title":"Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany","volume":"27","author":"Schwarz","year":"2021","journal-title":"Emerging Infectious Diseases"},{"key":"10.1002\/14651858.CD015021-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"10","key":"10.1002\/14651858.CD015021-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"e0052721","DOI":"10.1128\/JCM.00527-21","article-title":"Evaluation of cell-based and surrogate SARS-CoV-2 neutralization assays","volume":"59","author":"Sholukh","year":"2021","journal-title":"Journal of Clinical Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD015021-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1016\/S2214-109X(21)00043-7","article-title":"An interactive website tracking COVID-19 vaccine development","volume":"9","author":"Shrotri","year":"2021","journal-title":"Lancet Global Health"},{"issue":"8","key":"10.1002\/14651858.CD015021-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ccell.2021.06.002","article-title":"Seroconversion rates following COVID-19 vaccination among patients with cancer","volume":"39","author":"Thakkar","year":"2021","journal-title":"Cell Press"},{"issue":"11","key":"10.1002\/14651858.CD015021-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1016\/S2213-2600(21)00456-2","article-title":"Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers","volume":"9","author":"Tober-Lau","year":"2021","journal-title":"Lancet Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD015021-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015021-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1002\/14651858.CD015021-BIB0052|cit52","unstructured":"World Health Organization Establishment of the WHO international standard and reference panel for anti-SARS-CoV-2 antibody www.who.int\/publications\/m\/item\/WHO-BS-2020.2403"},{"key":"10.1002\/14651858.CD015021-BIB0053|cit53","unstructured":"World Health Organization WHO Coronavirus Disease (COVID-19) Dashboard www.covid19.who.int\u00a0"},{"key":"10.1002\/14651858.CD015021-BIB0054|cit54","unstructured":"World Health Organization Tracking SARS-CoV-2 variants www.who.int\/activities\/tracking-SARS-CoV-2-variants"},{"key":"10.1002\/14651858.CD015021-BIB0055|cit55","unstructured":"World Health Organization COVAX - Working for global equitable access to COVID-19 vaccines www.who.int\/initiatives\/act-accelerator\/covax"},{"issue":"10278","key":"10.1002\/14651858.CD015021-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and\u00a0 deployment","volume":"397","author":"Wouters","year":"2021","journal-title":"Lancet"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:47:25Z","timestamp":1771246045000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015021"}},"subtitle":[],"editor":[{"name":"Cochrane Haematology Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015021","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}